DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Weisberg E, Manley PW, Cowan-Jacob SW. et al.
Second generation inhibitors of bcr-abl for the treatment of imatinib-resistant chronic myeloid leukaemia.
Nature reviews Cancer 2007;
7: 345-356
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.